Paraneoplastic polyneuropathy preceding the diagnosis of Hodgkin's disease and non-small cell lung cancer in a patient with concomitant Borrelia burgdorferi infection

2001 ◽  
Vol 80 (4) ◽  
pp. 232-235 ◽  
Author(s):  
D. Behringer ◽  
A. Spyridonidis ◽  
S. Fetscher ◽  
A. Schmitt-Gräff ◽  
S. Högerle ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Borrelia Burgdorferi ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Hodgkin's Disease ◽  
Hodgkin’S Disease ◽  
Small Cell ◽  
Small Cell Lung ◽  
Paraneoplastic Polyneuropathy

Lung cancer in Hodgkin's disease: association with previous radiotherapy.

1985 ◽  
Vol 3 (2) ◽  
pp. 215-221 ◽  
Author(s):  
A F List ◽  
D C Doll ◽  
F A Greco
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Hodgkin's Disease ◽  
Hodgkin’S Disease ◽  
Combined Modality Therapy ◽  
Small Cell ◽  
Primary Therapy ◽  
Small Cell Lung ◽  
Increased Risk

Seven cases of lung cancer were observed in patients with Hodgkin's disease (HD) since 1970. The risk ratio for the development of lung cancer among HD patients was 5.6 times that expected in the general population. The pertinent clinical data from these patients are described and compared to 28 additional patients reported from other institutions. Small-cell lung cancer represented the predominant histologic type of lung cancer encountered in both smoking and nonsmoking patients with HD, accounting for 42% of cases overall and greater than 55% of cases reported in reviews of second malignancies. Tobacco use was noted in only 53% of patients. Twenty-eight (94%) of 30 patients developing metachronous lung cancer received supradiaphragmatic irradiation as primary therapy for HD. Nineteen (68%) of these patients received subsequent chemotherapy salvage. The median age at diagnosis of HD and lung cancer was 39 and 45 years, respectively. The interval between diagnosis of HD and metachronous lung cancer averaged seven years but appeared to vary inversely with age. HD patients treated with supradiaphragmatic irradiation or combined modality therapy may be at increased risk for developing lung cancer. The high frequency of in-field malignancies that we observed and the prevalence of small-cell lung cancer in both smoking and nonsmoking patients suggests that chest irradiation may influence the development of metachronous lung cancer in these patients. The finding of a mean latent interval in excess of seven years emphasizes the need for close long-term observation.

Abstract #829: Effect of Body Mass Index (BMI) and Lipids on Non-Small Cell Lung Cancer (NSCLC) Survival

2016 ◽  
Vol 22 ◽  
pp. 176
Author(s):  
Genevieve Streb ◽  
Narjust Duma ◽  
Natasha Piracha ◽  
Sejal Kothadia ◽  
Komal Patel ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Body Mass Index ◽  
Small Cell Lung Cancer ◽  
Body Mass ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung
Sign in / Sign up

Export Citation Format

Share Document